Gainwell Technologies Reports on Drug Utilization in NJ
Trusted by teams at
Description
Gainwell Technologies presents the NJ MCO 2nd Quarter 2025 Prior Authorization Report, offering insights into drug utilization and approval trends within New Jersey's managed care organizations. The report provides a detailed analysis of prior authorization requests, denial rates, and the reasons behind denials across various therapeutic drug classifications.
Contract Details
Contract Amount
NA
Vendor
GAINWELL
Agency
NJ Department of Human Services, NJ
Contract Type
Report
Document Date
October 22, 2025
Contract Term
NA
More from GAINWELL
More from NJ Department of Human Services
New Jersey Drug Utilization Review Board Agenda April 2026
nj-dhs-durb-agenda-drug-protocol-updates-utilization-trends-jul-16-2025_a3a.pdf
nj-dept-of-human-services-durb-agenda-drug-utilization-protocol-reviews-july-16-2025_b3a.pdf
nj-department-of-human-services-agenda-2025-04-23_0b7.pdf
nj-department-of-human-services-agenda-2025-04-23_0b7.pdf
Get alerts on contract renewals, new awards, and vendor activity.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.